Zentalis Pharmaceuticals, Inc.·4

Feb 12, 5:00 PM ET

Bruns Ingmar 4

4 · Zentalis Pharmaceuticals, Inc. · Filed Feb 12, 2025

Insider Transaction Report

Form 4
Period: 2025-02-06
Bruns Ingmar
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2025-02-06$2.28/sh+20,000$45,65636,629 total

Documents

1 file
  • 4
    wk-form4_1739397624.xmlPrimary

    FORM 4